In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells

In the last two decades, the exponential progress in the field of genetics could reveal the genetic impact on the onset and progression of several diseases affecting the immune system. This knowledge has led to the discovery of more than 400 monogenic germline mutations, also known as “inborn errors...

Full description

Bibliographic Details
Main Authors: Eirini Nikolouli, Janne Reichstein, Gesine Hansen, Nico Lachmann
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1024935/full
_version_ 1828098292085424128
author Eirini Nikolouli
Janne Reichstein
Gesine Hansen
Gesine Hansen
Gesine Hansen
Nico Lachmann
Nico Lachmann
Nico Lachmann
Nico Lachmann
author_facet Eirini Nikolouli
Janne Reichstein
Gesine Hansen
Gesine Hansen
Gesine Hansen
Nico Lachmann
Nico Lachmann
Nico Lachmann
Nico Lachmann
author_sort Eirini Nikolouli
collection DOAJ
description In the last two decades, the exponential progress in the field of genetics could reveal the genetic impact on the onset and progression of several diseases affecting the immune system. This knowledge has led to the discovery of more than 400 monogenic germline mutations, also known as “inborn errors of immunity (IEI)”. Given the rarity of various IEI and the clinical diversity as well as the limited available patients’ material, the continuous development of novel cell-based in vitro models to elucidate the cellular and molecular mechanisms involved in the pathogenesis of these diseases is imperative. Focusing on stem cell technologies, this review aims to provide an overview of the current available in vitro models used to study IEI and which could lay the foundation for new therapeutic approaches. We elaborate in particular on the use of induced pluripotent stem cell-based systems and their broad application in studying IEI by establishing also novel infection culture models. The review will critically discuss the current limitations or gaps in the field of stem cell technology as well as the future perspectives from the use of these cell culture systems.
first_indexed 2024-04-11T08:00:31Z
format Article
id doaj.art-9674080f81284c9b936d6b68c72dff43
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-11T08:00:31Z
publishDate 2022-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-9674080f81284c9b936d6b68c72dff432022-12-22T04:35:45ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-11-011310.3389/fimmu.2022.10249351024935In vitro systems to study inborn errors of immunity using human induced pluripotent stem cellsEirini Nikolouli0Janne Reichstein1Gesine Hansen2Gesine Hansen3Gesine Hansen4Nico Lachmann5Nico Lachmann6Nico Lachmann7Nico Lachmann8Department for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School (MHH), Hannover, GermanyDepartment for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School (MHH), Hannover, GermanyDepartment for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School (MHH), Hannover, GermanyCluster of Excellence - Resolving Infection Susceptibility (RESIST, EXC 2155), Hannover Medical School, Hannover, GermanyBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, GermanyDepartment for Pediatric Pneumology, Allergology and Neonatology, Hannover Medical School (MHH), Hannover, GermanyCluster of Excellence - Resolving Infection Susceptibility (RESIST, EXC 2155), Hannover Medical School, Hannover, GermanyBiomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, GermanyRegenerative Biology to Reconstructive Therapy (REBIRTH) Center for Translational and Regenerative Medicine, Hannover Medical School, Hannover, GermanyIn the last two decades, the exponential progress in the field of genetics could reveal the genetic impact on the onset and progression of several diseases affecting the immune system. This knowledge has led to the discovery of more than 400 monogenic germline mutations, also known as “inborn errors of immunity (IEI)”. Given the rarity of various IEI and the clinical diversity as well as the limited available patients’ material, the continuous development of novel cell-based in vitro models to elucidate the cellular and molecular mechanisms involved in the pathogenesis of these diseases is imperative. Focusing on stem cell technologies, this review aims to provide an overview of the current available in vitro models used to study IEI and which could lay the foundation for new therapeutic approaches. We elaborate in particular on the use of induced pluripotent stem cell-based systems and their broad application in studying IEI by establishing also novel infection culture models. The review will critically discuss the current limitations or gaps in the field of stem cell technology as well as the future perspectives from the use of these cell culture systems.https://www.frontiersin.org/articles/10.3389/fimmu.2022.1024935/fullinborn errors of immunityiPSCsdisease modelingcell therapiesimmune cellsmacrophages
spellingShingle Eirini Nikolouli
Janne Reichstein
Gesine Hansen
Gesine Hansen
Gesine Hansen
Nico Lachmann
Nico Lachmann
Nico Lachmann
Nico Lachmann
In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
Frontiers in Immunology
inborn errors of immunity
iPSCs
disease modeling
cell therapies
immune cells
macrophages
title In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
title_full In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
title_fullStr In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
title_full_unstemmed In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
title_short In vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
title_sort in vitro systems to study inborn errors of immunity using human induced pluripotent stem cells
topic inborn errors of immunity
iPSCs
disease modeling
cell therapies
immune cells
macrophages
url https://www.frontiersin.org/articles/10.3389/fimmu.2022.1024935/full
work_keys_str_mv AT eirininikolouli invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells
AT jannereichstein invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells
AT gesinehansen invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells
AT gesinehansen invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells
AT gesinehansen invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells
AT nicolachmann invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells
AT nicolachmann invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells
AT nicolachmann invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells
AT nicolachmann invitrosystemstostudyinbornerrorsofimmunityusinghumaninducedpluripotentstemcells